Henry Schein 2014 Annual Report Download - page 115

Download and view the complete annual report

Please find page 115 of the 2014 Henry Schein annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 131

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131

101
ITEM 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
None.
ITEM 9A. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of management, including our principal executive officer and
principal financial officer, we evaluated the effectiveness of the design and operation of our disclosure controls and
procedures as of the end of the period covered by this annual report as such term is defined in Rules 13a-15(e) and
15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on
this evaluation, our management, including our principal executive officer and principal financial officer,
concluded that our disclosure controls and procedures were effective as of December 27, 2014 to ensure that all
material information required to be disclosed by us in reports that we file or submit under the Exchange Act is
accumulated and communicated to them as appropriate to allow timely decisions regarding required disclosure and
that all such information is recorded, processed, summarized and reported within the time periods specified in the
SEC’ s rules and forms.
Changes in Internal Control over Financial Reporting
The combination of ongoing acquisition integrations and systems implementations undertaken during the
quarter ended December 27, 2014 and carried over from prior quarters, when considered in the aggregate,
represents a material change in our internal control over financial reporting.
During the quarter ended December 27, 2014, we completed the acquisition of a medical business in North
America with approximate aggregate annual revenues of $324.0 million. In addition, post-acquisition integration
related activities continued for our global dental and animal health businesses acquired during prior quarters,
representing aggregate annual revenues of approximately $389.0 million. These acquisitions, the majority of which
utilize separate information and financial accounting systems, have been included in our consolidated financial
statements.
System implementation activities were completed during the quarter ended December 27, 2014 for our
Australian animal health business with approximate aggregate annual revenues of $292.0 million. In addition, we
completed systems implementation solutions for dental businesses within Europe with approximate aggregate
annual revenues of $40.0 million. Finally, systems implementation activities were also completed for new ERP
systems that support our dental business in Thailand with approximate aggregate annual revenues of $18.0 million.
All acquisition integrations and systems implementations involved necessary and appropriate change-
management controls that are considered in our annual assessment of the design and operating effectiveness of our
internal control over financial reporting.